Renata Carvalho Cremaschi

Renata Carvalho Cremaschi

Auto-generated profile, based on publicly available information

Renata Carvalho Cremaschi

Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2018 in Journal of Sleep Research
Verified
Journal Article
Closed access
PDF file
RCRenata C. Cremaschi
Renata C. Cremaschi
CHCamila Hirotsu
Camila Hirotsu
STSergio Tufik
Sergio Tufik
FCFernando M. Coelho
Fernando M. Coelho

1 April 2017 in Sleep Medicine
Verified
Journal Article
Closed access
RCRenata Carvalho Cremaschi
Renata Carvalho Cremaschi
CHCamila Hirotsu
Camila Hirotsu
STSergio Tufik
Sergio Tufik
FCFernando Morgadinho Coelho
Fernando Morgadinho Coelho

16 May 2019 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
RSRodrigo de Andrade da Silva
Rodrigo de Andrade da Silva
RCRenata Carvalho Cremaschi
Renata Carvalho Cremaschi
João Renato Rebello PinhoJoão Renato Rebello Pinho
João Renato Rebello Pinho
JOJoão Bosco de Oliveira
João Bosco de Oliveira
FCFernando Morgadinho Coelho
Fernando Morgadinho Coelho

1 February 2023 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
RCRenata Carvalho Cremaschi
Renata Carvalho Cremaschi
CSCarla Scorza
Carla Scorza
APAngelo Amato Vincenzo de Paola
Angelo Amato Vincenzo de Paola
JAJaquelina Sonoe Ota Arakaki
Jaquelina Sonoe Ota Arakaki
PFPaulo Roberto Abrao Ferreira
Paulo Roberto Abrao Ferreira
FCFernando Morgadinho Santos Coelho
Fernando Morgadinho Santos Coelho
Background The neurological manifestations in COVID-19 adversely impact acute illness and post-disease quality of life. Limited data exist regarding the association of neurological symptoms and comorbid individuals. Objective To assess neurological symptoms in hospitalized patients with acute COVID-19 and multicomorbidities. Methods Between June 2020 and July 2020, inpatients aged 18 or older, with laboratory-confirmed COVID-19, admitted to the Hospital São Paulo (Federal University of São Paulo), a tertiary referral center for high complexity cases, were questioned about neurological symptoms. The Composite Autonomic Symptom Score 31 (COMPASS-31) questionnaire was used. The data were analyzed as a whole and whether subjective olfactory dysfunction was present or not. Results The mean age of the sample was 55 ± 15.12 years, and 58 patients were male. The neurological symptoms were mostly xerostomia (71%), ageusia/hypogeusia (50%), orthostatic intolerance (49%), anosmia/hyposmia (44%), myalgia (31%), dizziness (24%), xerophthalmia (20%), impaired consciousness (18%), and headache (16%). Furthermore, 91% of the patients had a premorbidity. The 44 patients with subjective olfactory dysfunction were more likely to have hypertension, diabetes, weakness, shortness of breath, ageusia/hypogeusia, dizziness, orthostatic intolerance, and xerophthalmia. The COMPASS-31 score was higher than that of previously published controls (14.85 ± 12.06 vs. 8.9 ± 8.7). The frequency of orthostatic intolerance was 49% in sample and 63.6% in those with subjective olfactory dysfunction (2.9-fold higher risk compared to those without). Conclusion A total of 80% of inpatients with multimorbidity and acute COVID-19 had neurological symptoms. Chemical sense and autonomic symptoms stood out. Orthostatic intolerance occurred in around two-thirds of the patients with anosmia/hyposmia. Hypertension and diabetes were common, mainly in those with anosmia/hyposmia.

1 January 2017 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
RFRicardo Humberto Felix
Ricardo Humberto Felix
CACarla Bezerra Lopes Almeida
Carla Bezerra Lopes Almeida
RCRenata Carvalho Cremaschi
Renata Carvalho Cremaschi
FCFernando Morgadinho Coelho
Fernando Morgadinho Coelho
FSFânia Cristina Santos
Fânia Cristina Santos
Objective: To study the quality of sleep in very elderly people with chronic pain. Methods: We investigated 51 very elderly people without dementia and with chronic pain according to the Geriatric Pain Measure. Katz and Lawton questionnaires were used to evaluate functionality. The Geriatric Depression Scale and Geriatric Psychosocial Assessment of Pain-induced Depression were also used. Self-perceptions of sleep and quality of sleep were checked using the Pittsburgh Sleep Quality Index. Results: Moderate pain was seen in 64.7% participants. The tracking of depression was positive for 41.2%. Poor quality of sleep was noted in 49% of them, but 82.3% perceived that they had a very good, or a good, sleep. The main factors associated with poor sleep quality were measurement of pain, self-perception of sleep, and pain-induced depression. Conclusion: Very elderly people with chronic pain, and without dementia, had a higher prevalence of poor sleep; however, they overestimated their sleep quality. Poor quality of sleep was associated with a poor self-perception of sleep and pain-induced depression.

1 December 2018 in Sleep Medicine
Verified
Journal Article
Closed access
RCRenata Carvalho Cremaschi
Renata Carvalho Cremaschi
CHCamila Hirotsu
Camila Hirotsu
STSergio Tufik
Sergio Tufik
FCFernando Morgadinho Coelho
Fernando Morgadinho Coelho